Frazier Life Sciences Management’s Elevation Oncology ELEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,993,579
Closed -$2.2M 50
2025
Q2
$2.2M Hold
5,993,579
0.09% 49
2025
Q1
$1.55M Hold
5,993,579
0.07% 47
2024
Q4
$3.37M Hold
5,993,579
0.14% 49
2024
Q3
$3.6M Buy
5,993,579
+3,035,000
+103% +$4.5M 0.14% 48
2024
Q2
$7.99M Buy
+2,958,579
New +$11.1M 0.37% 38

Other funds holding ELEV